key: cord-0902792-9wbkgzk4 authors: Sharif, Salman; Amin, Faridah; Hafiz, Mehak; Costa, Francesco; Dahlan, Rully Hanafi; Vaishya, Sandeep; Peev, Nikolay; Benzel, Edward title: A Year of Pandemic—Comparison of Depression Among Neurosurgeons After the Advent of the COVID-19 Vaccine date: 2021-12-29 journal: World Neurosurg DOI: 10.1016/j.wneu.2021.12.076 sha: b600a4a1820e6d28aaed934a477d4194c8c1647d doc_id: 902792 cord_uid: 9wbkgzk4 OBJECTIVE: To determine factors associated with anxiety and depression among neurosurgeons after vaccination during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: An online survey was completed by neurosurgeons worldwide over 4 weeks. Depression in neurosurgeons was assessed by the 20-item self-reporting questionnaire. RESULTS: A total of 534 responses were received and analyzed. Almost half of the respondents were from Asia (50.9%), followed by Europe (38.8%). The majority of the respondents were <40 years old (88%), and almost two thirds were trainees (62.2%). Half of the respondents worked in departments with <40 beds (50.7%), and the majority were practicing in the private sector (72.5%). Most of the respondents (85.8%) had COVID-19–positive colleagues in their department, and 64% had exposure to a COVID-19–positive colleague, family member, and/or patient. More than half of the respondents were exposed to infected patients and/or colleagues, and almost half (43.1%) underwent COVID-19 testing when exposed. Nearly half of the respondents underwent COVID-19 testing more than twice (52.4%). Of respondents, 83% had received at least the first dose of the vaccine. The odds of depression among vaccinated respondents were found to be significantly less than among unvaccinated respondents in the univariable model. CONCLUSIONS: Among health care workers, neurosurgeons are one of the groups indirectly affected by the pandemic. Adaptation to the new normal and advent of vaccines is speculated to control psychological distress among all groups of health care workers, including neurosurgeons. We found that odds of depression among vaccinated people were lower than among people who were not vaccinated. T he coronavirus disease 2019 (COVID-19) pandemic has acutely changed health care, transforming clinical services, modifying procedures, and altering standards of medical management. Urgent and emergent patient care dynamics have changed, pandemic, evaluating the frequency and factors associated with stress, depression, and anxiety. With a 14% prevalence, depression was significantly higher in neurosurgeons who did not feel safe with the provided personal protective equipment (PPE). Participants who had moderate concerns for the health of their families had lesser odds of anxiety and depression than those with more concerns. Being exposed to a COVID-19e positive colleague was also shown to significantly increase the likelihood of anxiety and/or depression. 3 The evolution of health care for >18 months of the pandemic led to specialists, including neurosurgeons, initially struggling to cope and eventually adapting to the surfacing situation. Therefore, we hypothesized that the initial distress this pandemic caused among neurosurgeons might have settled to a large extent, especially with vaccination and adaptation to a new normal. 4 Therefore, the aim of this study was to research how this specific group of HCWs is coping, including their current psychological health and associated factors after the advent of the vaccine. This cross-sectional study was conducted between May 1, 2021, and May 31, 2021, using an anonymous online questionnaire. Information only about the city location of respondents was collected Q6 to address the ethical implications of the survey. The questionnaire was modified based on suggestions from World Spinal Column Society (WSCS) executive board members. Most members of WSCS are neurosurgeons who also perform spinal surgery. The survey was designed on Google Forms (Google LLC, Mountain View, California, USA) and sent to neurosurgeons who were members of scientific societies globally through the WSCS Executive Committee. The survey was circulated to members of WSCS on their social media, WhatsApp (WhatsApp LLC, Menlo Park, California, USA) groups, and e-mails and through a snowballing technique locally and internationally. Neurosurgeons identified through these media were asked to forward the survey to other neurosurgeons in their professional circle. Of 1000 neurosurgeons who were approached, 534 responded. The methodology of this study was standardized and replicated from a previously published study in 2020, "COVID 19-Depression and Neurosurgeons," 3 to reassess the frequency and factors associated with anxiety and depression among neurosurgeons after a period of adaptation and the advent of vaccine. Consent was obtained from all individuals who completed the online questionnaire. The participant's identity and institution were not disclosed. All data were kept confidential in a passwordprotected computer. There was no financial compensation for participation or any penalty for not participating. The outcome and depression were assessed using the same scale as used previously with a World Health Organization validated questionnaire, the 20-item self-reporting questionnaire. 5 A cutoff score of 7 was considered as positive for depression. Independent variables were age (years), country, continent, consultant/resident self-rating of COVID-19 knowledge, level of practice, experience, size of department, number of consultants/ staff, number of trainees, level of awareness regarding selfprotection provided by current workplace, provision of adequate PPE at the workplace, training courses conducted for PPE use, safe practice with provided PPE by institution, presence of COVID-19e positive colleagues, redeployment to COVID-19eaffected area, perception about redeployment, concerns regarding the health of family members, perception of the family regarding workplace safety, exposure to the disease and severity, exposure to any positive colleague or family member, death of family member, polymerase chain reaction (PCR) testing, and vaccination. Categorical variables including age, designation, departmental size, number of trainees, self-rating of knowledge, feeling safe with provided PPE, family concerns, deployment in different areas, perception of the family about workplace safety, enough knowledge to deal if deployed, presence of COVID-19epositive colleagues, exposure to the disease and severity, exposure and death of a family member, PCR testing, vaccination, and 20-item selfreporting questionnaire were expressed as frequencies and percentages. The c 2 test was applied to compare study variables among depressed and nondepressed individuals. The McNemar test was used to see the difference in proportions of neurosurgeons performing elective surgeries in the previous and current studies. Univariate binary logistic regression was applied to determine the association of each independent variable with the outcome (anxiety/depression). Multivariate logistic regression was used to measure the association of multiple independent variables with the outcome (anxiety/depression) by computing adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Variables with a P value <0.05 were considered significant in the multivariate model. A total of 534 responses were received and analyzed. Respondents' characteristics are presented in Table 1 . Almost half of the respondents were from Asia (50.9%), followed by Europe (38.8%), Africa (4.9%), South America (2.8%), and North America (2.6%). The majority of the respondents were <40 years old (88%), and almost two thirds were trainees (62.2%). Half of the respondents worked in departments with <40 beds (50.7%), and the majority were practicing in the private sector (72.5%). Almost two thirds of respondents reported a moderate level of self-rated COVID-19 knowledge (59.2%). The majority were provided with PPE by their hospital (85%), and 58% had received PPE use training courses from their institution. Regarding practice, 68.5% of respondents felt safe to practice with provided PPE, while 59.2% had major concerns regarding family health. More than half (56.9%) reported that their families do not feel safe about them working. Most respondents (85.8%) have had COVID-19epositive colleagues in their department, while 64% had exposure to a COVID-19epositive colleague, family member, and/or patient. Half of respondents who needed admission reported that their hospital partially covered their treatment cost, one third (37.5%) reported complete compensation, and 12.5% did not receive any financial help from their organization. Almost one third of the respondents reported their family members had acquired the infection (34.5%), and 6.7% of family members died of COVID-19 infection. More than half of the respondents were exposed to infected patients and/or colleagues, and almost half (43.1%) underwent COVID-19 testing when exposed. Nearly half of the respondents underwent COVID-19 testing more than twice (52.4%). The biggest concern regarding COVID-19 was lack of adequate organization at the workplace (41%), followed by lack of adequate PPE (17.8%) and lack of adequate training for PPE usage (11.2%). Of respondents, 82% reported that elective surgeries were reduced in their departments during the pandemic, whereas nearly half reported a reduction in emergency cases (47.9%). The mean (SD) number of elective surgeries per week before and after the beginning of the pandemic was 22 (27) and 14 (28), while for emergency surgeries, the mean (SD) was 12 (17) and 12 (49), respectively. Redeployment to a COVID-19eaffected area was requested of 30% of respondents, and only 30.3% considered their knowledge and expertise to be meaningful in case of redeployment into a COVID-19eaffected area. Regarding vaccination, 83% of respondents received at least one dose of the vaccine, while 17% did not receive the vaccine. The most frequently administered vaccine was the Pfizer vaccine (42.9%), followed by the Chinese vaccine (38.4%), AstraZeneca 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 vaccine (13.1%), other vaccines (3.4%), and Russian vaccine (2.2%). Most of the respondents were from Asia and Europe, similar to the previous study, 3 but there were fewer respondents from North and South America in the current study ( Figure 1 ). More trainees than consultants participated, and the majority were working in private organizations (P < 0.001). Compared with previous studies, Q7 more neurosurgeons reported adequate provision of PPE by their organization (P < 0.001). More respondents felt safe to practice and did not have major concerns for their families (P < 0.001). Moreover, more respondents in the current study reported that their families felt safer about them going to work (P < 0.001). Responses regarding self-rated knowledge, adequate organization training, and redeployment to the COVID-19 area were not different between the previous and the current study. Figure 2 depicts the sources of knowledge for COVID-19 in the previous and current surveys. There was no significant difference in the pattern. The most frequent source of knowledge is a scientific publication, followed by a global network, local organization, social media, and local society. Figure 3 displays the respondents' opinions regarding the end of the pandemic in the current and the previous survey. In the previous survey, most respondents expected the pandemic to end within 4e8 weeks and 2e6 months. In the current survey, 54.5% thought it would take >6 months, while almost a quarter of the respondents had no idea when it would end. There were significant differences among responses recorded in the previous and the current survey (P < 0.001). Table 2 shows the comparison of symptoms of depression among respondents in the previous and the current survey. The overall prevalence of depression (score of 7) among survey respondents was 16.3% (87 of 534) compared with 14.1% (52 of 370) in the previous study (P ¼ 0.359). In the current survey, there was a significant rise in the frequency of headache (P < 0.001), feeling of fatigue (P ¼ 0.009), and tiredness (P ¼ 0.002). Fewer respondents reported poor appetite (P ¼ 0.005), feeling of unhappiness (P ¼ 0.014), difficulty in enjoying daily activities (P ¼ 0.020), and daily work suffering (P ¼ 0.002) in the current study compared with the previous study. Univariable and Multivariable Association of Respondents' Characteristics with Depression Table 3 presents univariable analysis of study variables among depressed and nondepressed survey respondents. There was no significant difference between depressed and nondepressed respondents in terms of age (P ¼ 0.009), continents (P ¼ 0.691), department size (P ¼ 0.972), number of consultants (P ¼ 0.992), number of residents (P ¼ 0.522), type of practice (P ¼ 0.993), self-rating of COVID-19 knowledge (P ¼ 0.246), attending training courses in use of PPE (P ¼ 0.178), positive COVID-19 colleagues in department (P ¼ 0.071), family members infected with COVID-19 (P ¼ 0.138), death in family owing to COVID-19 (P ¼ 0.053), exposure to positive COVID-19 cases (P ¼ 0.139), and impact of COVID-19 on elective (P ¼ 0.174) and emergency surgeries (P ¼ 0.181). Table 4 presents the multivariable ORs Q8 of depression according to patients' characteristics. The risk of depression was significantly lower in trainees (OR 0.51, 95% CI 0.32e0.80) than consultants. Depression was less likely among respondents who received enough information for their protection (OR 0.47, 95% CI 0.29e0.76), who were provided adequate PPE by their hospital (OR 0.35, 95% CI 0.20e0.60), and who felt safe to practice with provided PPE (OR 0.5, 95% CI 0.31e0.80). Odds of depression were lower among respondents with minor concerns regarding their family's health (OR 0.42, 95% CI 0.2e0.89) and whose families felt safe for them to go to work (OR 0.37, 95% CI 0.233e0.602). Odds of depression were also lower among vaccinated respondents (OR 0.46, 95% CI 0.27e0.79). 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 The odds of depression were higher among respondents who reported that their organization was not providing enough information on protection and infection (OR 2.36, 95% CI 1.06e5.22). Participants who did not feel safe to practice with provided PPE were significantly more likely to be depressed (OR 2.7, 95% CI 1.29e 5.64). Higher odds of depression were also observed for respondents who were infected with COVID-19 (OR 1.75, 95% CI 1.01e3.04) or were not sure if they had acquired the infection (OR 2.03, 95% CI 1.07e3.85) than for respondents who had not acquired the infection. The likelihood of depression was significantly higher in respondents who underwent the COVID-19 PCR test 2 times (OR 3.21, 95% CI 1.41e7.28) than those who were never tested for COVID-19. Redeployment to a COVID-19eaffected area significantly increased the odds of depression (OR 2.46, 95% CI 1.53e3.93). When the multivariable logistic regression model was adjusted for other covariates, Q9 higher odds of depression were observed in respondents who underwent COVID-19 PCR testing 2 times than those who were never tested for COVID-19 (adjusted OR 3.08, 95% CI 1.20e7.90). The risk of depression was lower for respondents who reported that their family considered it safe for them to go to work (adjusted OR 0.48, 95% CI 0.27e0.87). The likelihood of depression was higher in respondents who were re-deployed to a COVID-19 area (adjusted OR 2.81, 95% CI 1.62e4.87) than in those who were not displaced. Globally, as of June 2, 2021, 172,630,637 confirmed cases of COVID-19, including 3,718,683 deaths, were reported to the World Health Organization. 6 One third of COVID-19 survivors develop neurological or mental disorders, as stated in one study. 7 A rapid review of 44 studies regarding the psychological impact of pandemic outbreaks on HCWs reported posttraumatic stress symptoms during outbreaks, with symptoms lasting beyond 1e3 years in 10%e40% of the individuals. 8 The medical profession and institutions worldwide responded and continue to modify their response as the COVID-19 pandemic unfolds. Various guidelines have been published, and several measures are being taken to safeguard the physical and psychological well-being of HCWs and medical specialists. This is a follow-up study after 1 year of the pandemic, which included the participation of neurosurgeons around the globe to assess the frequency and modification of factors associated with depression. As policies and procedures were modified and concerns of infection among HCWs were addressed by hospital administrations, 9 more neurosurgeons in this study reported adequate provision of PPE by their organization than in the previous study. Another study published at the beginning of the pandemic reported only 12% of the physicians were fully satisfied with the provision of PPE, while almost 94% felt unprotected. 10 Suboptimal standard operating procedures and lack of provision of PPE were significantly associated with depression in the previous study and univariate analysis of the current study data. Therefore, with the majority of neurosurgeons provided with adequate PPE within a year, they feel safer to practice and have fewer concerns for their families. Although the majority of the neurosurgeons have had exposure to an infected patient, one third had an infected family member, almost 7% reported death in the family owing to COVID-19, and 20% were infected themselves; yet, families significantly felt safer for them to continue to practice in the current study. Moreover, in the multivariable model, the risk of depression was lower for respondents who reported that their family considered it safe for them to go to work. This indicates that institutional support, provision of PPE, training in use of PPE, Q10 redesigning organizational models, and modified guidelines to safeguard the health of neurosurgeons alleviated their fear and consoled their families to a large extent. The dynamics of the pandemic evolved, yet the frequency of depression did not decrease significantly, as the medical profession continued to face different dilemmas and new challenges. 1, 11 We found higher odds of depression among neurosurgeons who underwent COVID-19 PCR testing 2 times than neurosurgeons who were never tested. Repeated COVID-19 testing may be associated with higher exposure, frequency of flulike symptoms, and 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 anxiety regarding a positive result, which may predispose to distress and hence depression. Yet, it is interesting to note that although respondents who were tested twice were more likely to be depressed, a similar association was not seen with multiple testing. There is a possibility that neurosurgeons who had a PCR test more than twice in a year did it as a routine institutional policy and not because of symptoms, contact, or a higher possibility of infection, whereas a PCR test that was done twice was more likely due to direct exposure or symptoms and hence the anxiety. The frequency of deployment to a COVID-19 area was similar in both the previous and the current study, yet this was a significant factor associated with depression in the current study. This means that neurosurgeons were able to adjust and adapt to their working environment within a year despite a significant reduction in elective and emergency procedures reported by the majority of respondents. Yet, it can be assumed that a change in a niche can lead to distress and hence depression among neurosurgeons, possibly owing to maladaptation. 12 We hypothesized that there would be a decline in the frequency of depression after a year owing to better organizational support and coping skills. Yet, the prevalence was higher, though not statistically significant, than in the previous study. Similarly, our study revealed a significant increase in the frequency of headaches, fatigue, and tiredness. Relatively younger respondents in this study than in the previous study may explain this. This assumption is supported by another study in Turkish neurosurgeons, which showed that older experienced neurosurgeons were better able to combat depression symptoms than younger ones. 13 Although significantly more respondents thought that the pandemic would end sooner in the previous study, this study revealed that a quarter of neurosurgeons were clueless regarding when the pandemic would end. Interestingly, after a year of hopelessness and despair, significantly fewer respondents reported poor appetite, feeling of unhappiness, difficulty enjoying daily activities, and daily work suffering in this study. Overall, the frequency of depression among neurosurgeons was relatively less in both surveys than the rate reported among frontline HCWs directly involved with COVID-19 patients. [14] [15] [16] [17] For example, a previous study showed an alarming 43% prevalence of anxiety and depression among frontline physicians in Pakistan. 4 Finally, the advent of the COVID-19 vaccine is speculated to halt the pandemic and alleviate the associated psychological distress among the general population and HCWs. As of June 2, 2021, a total of 1,638,006,899 vaccine doses have been administered. 6 However, even though researchers discovered the morphology, pathophysiology, and treatment of the virus, new strains and different variants of the 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 novel coronavirus were also identified. 18 Hence, we are still combating wave after wave of mutant strains. 19 Despite the ongoing pandemic, with the advent of vaccines, we hypothesized that vaccination would reduce the psychological distress, creating a sense of being protected. In our survey, 83% of respondents had received at least the first dose of the vaccine. We found that the odds of depression among vaccinated respondents were significantly less than among unvaccinated respondents in the univariable model. This variable was not significant in the multivariable model, although there was a trend. This could be explained by the findings of initial studies indicating a low uptake, acceptance, and apprehension among HCWs regarding different vaccines and their adverse effects. 16, 17 As our survey was done during the first 3 months of vaccination administration, we did not find a significant change in the sense of protection, reduction in distress, and hence depression among neurosurgeons. A recent qualitative analysis of 13 studies regarding the efficacy of 11 COVID-19 vaccines concluded that most COVID-19 vaccines appear to be effective and safe. 20 Therefore, with proven effectiveness and reduction in morbidity with infection, the apprehension among HCWs may be put to rest. Participation bias is unavoidable in online surveys, yet this was the best possible data collection method from neurosurgeons worldwide during the pandemic. More trainees than consultants from private institutions of Asia and Europe responded to the current online survey. There is a possibility that workloads of consultants were returning to near normal, especially in the United States. The vaccination rate in developed countries was also much higher than in other regions. A bombardment of online surveys and educational activities may also have led to a low response rate among consultants. Therefore, the discrepancy in respondents' characteristics is evident, although the identical mechanism was deployed for data collection. The previous and current studies did not compare the baseline rate of mental health problems in neurosurgeons with the rate during the pandemic because no data were reported before the pandemic to evaluate the psychological health of physicians in a competitive specialty such as neurosurgery. However, it can be reasonably assumed that even though the prevalence at baseline may not be different, the associated factors are considerably diverse at each phase of the pandemic. Hence, the steps taken to control damage to psychological health should be guided by the underlying factors, as indicated by this study. Among HCWs, neurosurgeons are one of the indirectly affected groups by the COVID-19 pandemic. Although vaccination status was significant in univariate analysis, it was insignificant in the multivariable model, which may be because of an inadequate vaccination uptake by respondents at the time of the survey. Yet, adaptation to the new normal and advent of vaccines are speculated to control psychological distress among HCWs, including neurosurgeons. We recommend ongoing intervention to prevent psychological distress among neurosurgeons, which may be due to multiple dynamic factors. 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 Adapting to the unpredictable. My experience as a neurosurgeon-hypnologist offering treatment to health professionals in a Covid-19 converted hospital COVID-19 pandemic prevalence and risk factors for depression among health care workers in South Asia COVID 19-depression and neurosurgeons Validation of the WHO self-reporting questionnaire-20 (SRQ-20) item in primary health care settings in Eritrea World Health Organization. A User's Guide to the Self-Reporting Questionnaire (SRQ) World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https:// covid19.who.int/. Accessed A third of COVID survivors suffer neurological or mental disorders: study The psychological impact of epidemic and pandemic outbreaks on healthcare workers: rapid review of the evidence World Health Organization. Country & Technical Guidance-Coronavirus disease (COVID-19) COVID-19 pandemic-knowledge, perception, anxiety and depression among frontline doctors of Pakistan The impact of COVID-19 on neurosurgeons and the strategy for triaging non-emergent operations: a global neurosurgery study The effect of the COVID-19 pandemic on functioning of neurosurgery clinics and the anxiety levels of neurosurgeons in Turkey Psychological effects of COVID-19 on hospital staff: a national crosssectional survey of China mainland Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based crosssectional survey The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a crosssectional survey Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis Arduman E. Anxiety, uncertainty, and resilience during the pandemic: "re-directing the gaze of the therapeutic couple Efficacy and safety of COVID-19 vaccines: a systematic review Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.